Table 3.
Consultant specialty | Ages 5–11 (n = 2330) | Ages 12–17 (n = 30,701) | SSRI (n = 22,130) | TCA (n = 10,489) | Any antidepressant ages 5–17 (n = 33,031) |
---|---|---|---|---|---|
Any paediatric or psychiatric | 1157 (49.7%) | 10,992 (35.8%) | 8387 (37.9%) | 3625 (34.6%) | 12,149 (36.8%) |
Adult mental illness | 13 (0.6%) | 900 (2.9%) | 833 (3.8%) | 54 (0.5%) | 913 (2.8%) |
Child and adolescent psychiatry | 285 (12.2%) | 5770 (18.8%) | 5463 (24.7%) | 522 (5.0%) | 6055 (18.3%) |
Forensic psychiatry | < 10 | 10 (< 0.1%) | < 10 | < 10 | 10 (< 0.1%) |
Paediatric neurology | 124 (5.3%) | 567 (1.8%) | 259 (1.2%) | 424 (4.0%) | 691 (2.1%) |
Paediatrics | 1000 (42.9%) | 6154 (20.0%) | 3940 (17.8%) | 3144 (30.0%) | 7154 (21.7%) |
Psychotherapy | 13 (0.6%) | 79 (0.3%) | 53 (0.2%) | 39 (0.4%) | 92 (0.3%) |
Includes visits made less than 1 year before or 6 months after the first antidepressant prescription. Individuals may be included in both SSRI and TCA categories and may have visited more than one type of specialist. Counts less than 10 have been masked
SSRI selective serotonin reuptake inhibitor, TCA tricyclic and related antidepressant, n number